How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

0 Umsagnir
0
Episode
263 of 286
Lengd
31Mín.
Tungumál
enska
Gerð
Flokkur
Óskáldað efni

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.


Hlustaðu og lestu

Stígðu inn í heim af óteljandi sögum

  • Lestu og hlustaðu eins mikið og þú vilt
  • Þúsundir titla
  • Getur sagt upp hvenær sem er
  • Engin skuldbinding
Prófa frítt
is Device Banner Block 894x1036
Cover for How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

Other podcasts you might like ...